post ESD ulcer
Conditions
Interventions
Doing H. pylori eradication therapy before ESD
Not doing H. pylori eradication therapy before ESD
Sponsors
Tokai University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patients planned ESD due to early stomach cancer or suspicious of the cancer
Exclusion criteria
Exclusion criteria: Patients without H. pylori infection Patients with the history of gastric surgeries Patients with alarm symptoms such as vomiting, GI bleeding, rapid body weight loss Patients with alcohol/drug dependence Patients with severe endocrine problems Patients with severe injuries of heart, liver, kidney or bone marrow functions Patients with allergy against the test drugs Patients with pregnancy, possible pregnancy or breast feeding, or hope of pregnancy during the test period Patients whom the doctor decide as not proper for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The ratio of ulceration area after 1 month of ESD compared with that of right after ESD | — |
Secondary
| Measure | Time frame |
|---|---|
| Cure rate of ulcers (4W, 8W after ESD) H. pylori eradication rate H. pylori infection rate Background of the patients Compliance of the medications | — |
Countries
Japan
Contacts
Public ContactMasashi Matsushima
Tokai University School of Medicine Internal Medicine (Gastroenterology)
Outcome results
None listed